XOOMAR
Get a free API key

Calidi Biotherapeutics (CLDI)

Calidi Biotherapeutics on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on NYSE.

Download CSV

164K

Short interest

settlement 2026-10-15

4.2

Days to cover

+3.2 days vs prior

23.7%

Short share of volume

2026-11-02

1,520

Fails to deliver

settlement 2026-10-07

Thu 12 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in CLDI is 164,295 shares, down 63,480 shares over the last month. Over the last 48 readings it ranged from 58,304 shares (27 February 2026) to 7,806,179 shares (31 July 2025). The latest reading sits at the bottom of that range. At the reported average volume of 39K shares a day that is 4.2 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/cldi" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-15164,295-29.6%39,2274.19
2026-09-30233,287+2.4%380,1011.00
2026-09-15227,775-1.4%36,5726.23
2026-08-31231,117-26.2%98,1002.36
2026-08-14313,261+35.4%201,5761.55
2026-07-31231,318-93.2%665,8881.00
2026-07-153,421,439-20.0%2,133,8661.60
2026-06-304,276,018+251.3%6,265,1611.00
2026-06-151,217,102+63.6%4,877,8891.00
2026-05-29743,922+10.9%2,295,4261.00
2026-05-15670,614-77.9%2,410,7481.00
2026-04-303,038,967+1004.7%17,378,1631.00
2026-04-15275,084+12.6%1,379,4391.00
2026-03-31244,357+31.0%369,6031.00
2026-03-13186,549+220.0%710,0181.00
2026-02-2758,304-44.1%47,1141.24
2026-02-13104,240-59.8%102,3831.02
2026-01-30259,453+154.8%82,5343.14
2026-01-15101,823-34.1%75,4701.35
2025-12-31154,542+116.7%86,6901.78
2025-12-1571,326-28.7%66,7261.07
2025-11-28100,053-41.3%101,3801.00
2025-11-14170,321+91.9%347,4141.00
2025-10-3188,736-26.3%117,8231.00
2025-10-15120,339-54.7%205,4601.00
2025-09-30265,547-10.1%124,1242.14
2025-09-15295,520-21.7%217,4381.36
2025-08-29377,501+39.8%754,1521.00
2025-08-15270,020-96.5%183,8461.47
2025-07-317,806,179+124.8%18,087,3001.00
2025-07-153,472,354+184.2%81,477,4451.00
2025-06-301,221,840+233.3%2,829,2881.00
2025-06-13366,602+24.6%795,9801.00
2025-05-30294,158+9.2%261,9921.12
2025-05-15269,387+18.0%201,7931.33
2025-04-30228,236+33.4%224,9371.01
2025-04-15171,127-80.3%425,3761.00
2025-03-31870,894+36.2%345,4582.52
2025-03-14639,393-17.5%572,4301.12
2025-02-28775,187-32.8%886,2021.00
2025-02-141,153,261+67.3%3,999,6031.00
2025-01-31689,205+34.3%1,293,0891.00
2025-01-15513,274+156.5%1,546,0561.00
2024-12-31200,128-69.8%1,021,4691.00
2024-12-13663,015-27.9%1,033,9711.00
2024-11-29919,014-53.1%1,537,2251.00
2024-11-151,958,173+234.4%4,839,0131.00
2024-10-31585,626+428.4%1,276,7011.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of CLDI volume is 23.7%, down 52.8 points over the last five sessions. Over the last 30 readings it ranged from 3.2% (9 October 2026) to 76.5% (26 October 2026). The latest reading is 3.7 points below the 30-session average of 27.5%, on 21K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-025K21K23.7%0
2026-10-306K16K39.6%0
2026-10-295K12K39.9%0
2026-10-282K13K13.7%0
2026-10-275K18K26.4%0
2026-10-2615K19K76.5%0
2026-10-236K24K25.7%47
2026-10-2229K139K20.8%1,737
2026-10-2117K55K30.7%0
2026-10-202K15K12.3%1,801
2026-10-191K18K6.4%127
2026-10-167K26K27.3%0
2026-10-157K15K42.3%0
2026-10-145K30K15.9%0
2026-10-139K32K27.0%0
2026-10-1210K30K31.9%0
2026-10-0939812K3.2%0
2026-10-082K8K18.1%0
2026-10-0712K32K36.4%0
2026-10-0614K51K26.6%0
2026-10-052K5K45.0%0
2026-10-0210K21K47.2%0
2026-10-012K10K15.6%0
2026-09-303K29K11.9%0
2026-09-296K28K21.3%0
2026-09-2821K111K18.9%400
2026-09-2520K69K29.5%3,600
2026-09-2489K280K31.7%0
2026-09-2320K44K45.5%6,948
2026-09-222K17K13.3%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 7 October 2026, the fails-to-deliver balance in CLDI is 1,520 shares, up 294 shares over the last settlement date. Over the last 30 readings it ranged from 11 shares (17 September 2026) to 107,139 shares (3 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-071,520$1.02$2K
2026-10-061,226$1.05$1K
2026-10-052,352$1.08$3K
2026-09-29610$1.07$653
2026-09-2811,404$1.13$13K
2026-09-2516,000$1.20$19K
2026-09-2456,182$1.09$61K
2026-09-189,037$1.27$11K
2026-09-1711$1.17$13
2026-09-16162$1.17$190
2026-09-151,141$1.22$1K
2026-09-142,605$1.24$3K
2026-09-0227$1.33$36
2026-08-3139$1.32$51
2026-08-252,580$1.38$4K
2026-08-2425,109$1.34$34K
2026-08-2123,690$1.34$32K
2026-08-2026,983$1.38$37K
2026-08-1832$1.36$44
2026-08-1318$1.63$29
2026-08-1230,209$1.64$50K
2026-08-1112,887$1.63$21K
2026-08-106,330$1.62$10K
2026-08-0740,663$1.79$73K
2026-08-0613,649$1.76$24K
2026-08-0513,571$1.89$26K
2026-08-0415,053$1.68$25K
2026-08-03107,139$1.64$176K
2026-07-307,384$0.09$665
2026-07-2914,123$0.11$2K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for CLDI in the last 90 days. The most recent filings are listed below. Latest filing: Camaisa Allan (Director) on 2025-12-12.

DateInsiderTitleTypeSharesPriceValueOwned after
2025-12-12Camaisa AllanDirectorSell850$1.46$1K77K
2025-08-21Schoeneck James ADirectorBuy75K$2.00$150K76K
2025-08-21Poma Eric EChief Executive OfficerBuy25K$2.00$50K25K
2025-08-21Leftwich ScottDirectorBuy125K$2.00$250K131K
2025-08-21Jackson Andrew C.Chief Financial OfficerBuy3K$2.00$5K3K
2024-12-31Leftwich ScottDirectorGrant12Kprice not stated in the filingnot stated68K
2024-12-31Stewart Alan R.DirectorGrant13Kprice not stated in the filingnot stated29K
2024-12-17Camaisa AllanCEO and Chairman of the BoardSell10K$1.62$16K67K
2024-09-26Camaisa AllanCEO and Chairman of the BoardGrant70K$1.15$81K77K
2024-06-28Stewart Alan R.DirectorGrant73Kprice not stated in the filingnot stated154K
2024-06-28Schoeneck James ADirectorGrant80Kprice not stated in the filingnot stated1.1M
2024-06-28Leftwich ScottDirectorGrant67Kprice not stated in the filingnot stated561K
2024-06-03Schoeneck James ADirectorExercise or conversion173K$0.20$35K589K
2024-06-03Schoeneck James ADirectorExercise or conversion375K$0.20$75K964K
2024-04-18Schoeneck James ADirectorGrant375K$0.40$150K416K
2024-03-29Stewart Alan R.DirectorGrant26Kprice not stated in the filingnot stated81K
2024-03-29Schoeneck James ADirectorGrant28Kprice not stated in the filingnot stated992K
2024-03-29Leftwich ScottDirectorGrant24Kprice not stated in the filingnot stated494K
2023-12-21Leftwich ScottDirectorGrant9K$1.80$16K470K
2023-12-21Schoeneck James ADirectorGrant11K$1.80$19K28K
2023-12-21Stewart Alan R.DirectorGrant7K$1.80$13K55K
2023-12-21Zulueta Alfonso GDirectorGrant6K$1.80$10K133K
2023-12-21Vecchiolla Thomas A.DirectorGrant8K$1.80$14K365K
2023-09-12Vecchiolla Thomas A.DirectorConversion6Kprice not stated in the filingnot stated6K
2023-09-12FLAG Sponsor Manager, LLCTenPercentOwnerConversion1.9Mprice not stated in the filingnot stated1.9M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

No holder on file reports 5% or more of CLDI in its latest filing.

FiledFormHolderSharesOf classEvent
2026-08-1413G/Ano. 1Armistice Capital, LLCinvestment adviser, other entity63K5.0%2026-06-30
2026-08-1413G/Ano. 1Steven Boydparent holding company, individual63K5.0%2026-06-30
2026-03-3113DGavrilov Ognian Anguelovindividual20K0.3%2026-03-31
2026-02-1013G/Ano. 1Lincoln Alternative Strategies LLCother entity00.0%2025-09-18

What this page is

Calidi Biotherapeutics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Calidi Biotherapeutics (CLDI), SEC CIK 1855485, listed on NYSE. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-07.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-12-12.JSON and CSV
Company record
EDGAR filing index for CIK 1855485Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other company pages

Datasets

Frequently Asked Questions

How much of CLDI is sold short?
164,295 shares were held short at the 2026-10-15 settlement, 4.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is CLDI's daily short volume?
On 2026-11-02, 4,995 of the 21,039 CLDI shares reported to FINRA were sold short, 23.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does CLDI have fails to deliver?
The SEC's latest file shows 1,520 CLDI shares failed to deliver at settlement 2026-10-07. Fails are reported per settlement date and published twice a month with a lag.
Are CLDI insiders buying or selling?
No open-market insider trades were reported for CLDI in the last 90 days. The most recent filings are listed below. Latest filing: Camaisa Allan (Director) on 2025-12-12.
Who owns 5% or more of CLDI?
No holder on file reports 5% or more of CLDI in its latest filing.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.